orphan nuclear receptor modulators (Orphagen)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameorphan nuclear receptor modulators (Orphagen)
Drug Alias Nameorphan nuclear receptor modulators (Orphagen)Orphan nuclear receptor modulators (Orphagen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrphan nuclear receptors modulators
TargetsOrphan nuclear receptors
Therapy Area/IndicationsGeographic AtrophyRetinitis PigmentosaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOrphagen Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrphagen Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsGeographic AtrophyRetinitis PigmentosaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A